TY - JOUR AU - Bouvard, V. AU - Baan, R. AU - Straif, K. AU - Ghissassi, F. AU - Benbrahim-Tallaa, L. AU - Guha, N. PY - 2009 DA - 2009// TI - On behalf of the WHO IARC in Cancer monograph working group. A review of human carcinogens –part B: biological agents JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70096-8 DO - 10.1016/S1470-2045(09)70096-8 ID - Bouvard2009 ER - TY - STD TI - Ronco G, Dillner J, Elfström M, Tunesi S, Snijders PJ, Arbyn M, et al. International HPV screening working group. Efficacy of HPV-based screening for preventing invasive cervical cancer: follow-up of European randomised controlled trials. Lancet. 2014;383:524–32. ID - ref2 ER - TY - CHAP AU - Ronco, G. AU - Arbyn, M. AU - Meijer, C. J. L. M. AU - Snijders, P. J. F. AU - Cuzick, J. ED - Anttila, A. ED - Arbyn, M. ED - Vuyst, H. ED - Dillner, J. ED - Dillner, L. ED - Franceschi, S. ED - Patnick, J. ED - Ronco, G. ED - Segnan, N. ED - Suonio, E. ED - Törnberg, S. ED - Karsa, L. PY - 2015 DA - 2015// TI - Screening for cervical cancer with primary testing for human papillomavirus. S1 BT - European guidelines for quality assurance in cervical cancer screening. Second edition, Supplements PB - Office for Official Publications of the European Union CY - Luxembourg ID - Ronco2015 ER - TY - STD TI - Ronco G, Biggeri A, Confortini M, Naldoni C, Segnan N, Sideri M, et al. Health Technology Assessment report: HPV DNA based primary screening for cervical cancer precursors. Epidemiol Prev. 2012;36(3–4 Suppl 1):1–72. Italian. ID - ref4 ER - TY - JOUR AU - Meijer, C. J. AU - Berkhof, J. AU - Castle, P. E. AU - Hesselink, A. T. AU - Franco, E. L. AU - Ronco, G. PY - 2009 DA - 2009// TI - Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.24010 DO - 10.1002/ijc.24010 ID - Meijer2009 ER - TY - JOUR AU - Ratnam, S. AU - Jang, D. AU - Gilchrist, J. AU - Smieja, M. AU - Poirier, A. AU - Hatchette, T. PY - 2014 DA - 2014// TI - Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections JO - J Clin Microbiol VL - 52 UR - https://doi.org/10.1128/JCM.03549-13 DO - 10.1128/JCM.03549-13 ID - Ratnam2014 ER - TY - JOUR AU - Zorzi, M. AU - Mistro, A. AU - Farruggio, A. AU - de’ Bartolomeis, L. AU - Frayle Salamanca, H. AU - Baboci, L. PY - 2013 DA - 2013// TI - Use of high-risk human papillomavirus DNA test as primary test in a cervical cancer screening programme: a population-based cohort study JO - BJOG VL - 120 UR - https://doi.org/10.1111/1471-0528.12272 DO - 10.1111/1471-0528.12272 ID - Zorzi2013 ER - TY - JOUR AU - Mistro, A. AU - Frayle, H. AU - Ferro, A. AU - Callegaro, S. AU - Sole, A. AU - Stomeo, A. PY - 2014 DA - 2014// TI - On behalf of the Veneto HPV-screening working group. Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women JO - J Med Screen VL - 21 UR - https://doi.org/10.1177/0969141314522219 DO - 10.1177/0969141314522219 ID - Mistro2014 ER - TY - JOUR AU - Zorzi, M. AU - Frayle, H. AU - Rizzi, M. AU - Fedato, C. AU - Rugge, M. AU - Penon, M. G. PY - 2017 DA - 2017// TI - A 3-year interval is too short for re-screening HPV negative women: a population-based cohort study JO - BJOG VL - 124 UR - https://doi.org/10.1111/1471-0528.14575 DO - 10.1111/1471-0528.14575 ID - Zorzi2017 ER - TY - JOUR AU - Heideman, D. A. AU - Hesselink, A. T. AU - Berkhof, J. AU - Kemenade, F. AU - Melchers, W. J. AU - Fransen, D. N. PY - 2011 DA - 2011// TI - Clinical validation of the cobas(R)4800 HPV test for cervical screening purposes JO - J Clin Microbiol VL - 49 UR - https://doi.org/10.1128/JCM.05552-11 DO - 10.1128/JCM.05552-11 ID - Heideman2011 ER - TY - JOUR AU - Lloveras, B. AU - Gomez, S. AU - Alameda, F. AU - Bellosillo, B. AU - Mojal, S. AU - Muset, M. PY - 2013 DA - 2013// TI - HPV testing by cobas HPV test in a population from Catalonia JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0058153 DO - 10.1371/journal.pone.0058153 ID - Lloveras2013 ER - TY - JOUR AU - Cobb, B. AU - Simon, C. O. AU - Stramer, S. L. AU - Body, B. AU - Mitchell, P. S. AU - Reisch, N. PY - 2017 DA - 2017// TI - The cobas 6800/8800 system: a new era of automation in molecular diagnostics JO - Expert Rev Molec Diagn VL - 17 UR - https://doi.org/10.1080/14737159.2017.1275962 DO - 10.1080/14737159.2017.1275962 ID - Cobb2017 ER - TY - JOUR AU - Engesaeter, B. AU - Diermen Hidle, B. AU - Hansen, M. AU - Moltu, P. AU - Staby, K. M. AU - Borchgrevink-Persen, S. PY - 2016 DA - 2016// TI - Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study JO - BMC Infect Dis VL - 16 UR - https://doi.org/10.1186/s12879-016-2028-7 DO - 10.1186/s12879-016-2028-7 ID - Engesaeter2016 ER - TY - JOUR AU - Schiffman, M. AU - Glass, A. G. AU - Wentzensen, N. AU - Rush, B. B. AU - Castle, P. E. AU - Scott, D. R. PY - 2011 DA - 2011// TI - A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser cohort study JO - Cancer Epidemiol Biomark Prev VL - 20 UR - https://doi.org/10.1158/1055-9965.EPI-11-0206 DO - 10.1158/1055-9965.EPI-11-0206 ID - Schiffman2011 ER - TY - JOUR AU - Simms, K. T. AU - Hall, M. AU - Smith, M. A. AU - Lew, J. B. AU - Hughes, S. AU - Yuill, S. PY - 2017 DA - 2017// TI - Optimal management strategies for primary HPV testing for cervical screening: cost-effectiveness evaluation for the national cervical screening program in Australia JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0163509 DO - 10.1371/journal.pone.0163509 ID - Simms2017 ER - TY - JOUR AU - Luttmer, R. AU - Strooper, L. M. A. AU - Steenbergen, R. D. M. AU - Berkhof, J. AU - Snijders, P. J. F. AU - Heideman, D. A. M. AU - Meijer, C. J. L. M. PY - 2016 DA - 2016// TI - Management of high-risk HPV-positive women for detection of cervical (pre)cancer JO - Exp Rev Mol Diagn VL - 16 UR - https://doi.org/10.1080/14737159.2016.1217157 DO - 10.1080/14737159.2016.1217157 ID - Luttmer2016 ER - TY - JOUR AU - Rijkaart, D. C. AU - Berkhof, J. AU - Kemenade, F. J. AU - Coupe, V. M. AU - Hesselink, A. T. PY - 2012 DA - 2012// TI - Rozendaal, et al. evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening JO - Int J Cancer VL - 130 UR - https://doi.org/10.1002/ijc.26056 DO - 10.1002/ijc.26056 ID - Rijkaart2012 ER - TY - JOUR AU - Wentzensen, N. AU - Arbyn, M. AU - Berkhof, J. AU - Bower, M. AU - Canfell, K. AU - Einstein, M. PY - 2017 DA - 2017// TI - Eurogin 2016 roadmap: how HPV knowledge is changing screening practice JO - Int J Cancer VL - 140 UR - https://doi.org/10.1002/ijc.30579 DO - 10.1002/ijc.30579 ID - Wentzensen2017 ER - TY - JOUR AU - Vermehren, J. AU - Stelzl, E. AU - Maasoumy, B. AU - Michel-Treil, V. AU - Berkowski, C. AU - Marins, E. G. PY - 2017 DA - 2017// TI - Multicenter comparison study of both analytical and clinical performance across four Roche hepatitis C virus RNA assays utilizing different platforms JO - J Clin Microbiol VL - 55 UR - https://doi.org/10.1128/JCM.02193-16 DO - 10.1128/JCM.02193-16 ID - Vermehren2017 ER -